Cargando…
Sorafenib-Loaded Cu(2−x)Se Nanoparticles Boost Photothermal–Synergistic Targeted Therapy against Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) accounts for the predominant form of liver malignancy and presents a leading cause of cancer-related death globally. Sorafenib (SOR), a first-line targeted drug for advanced HCC treatment, has a battery of untoward side effects. Photothermal therapy (PTT) has been util...
Autores principales: | Huang, An-Tian, Du, Jun, Liu, Zhi-Yong, Zhang, Guang-Cong, Abuduwaili, Weinire, Yan, Jia-Yan, Sun, Jia-Lei, Xu, Ru-Chen, Liu, Tao-Tao, Shen, Xi-Zhong, Dong, Ling, Zhu, Ji-Min, Li, Yuhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505850/ https://www.ncbi.nlm.nih.gov/pubmed/36144982 http://dx.doi.org/10.3390/nano12183191 |
Ejemplares similares
-
Nalidixic acid potentiates the antitumor activity in sorafenib-resistant hepatocellular carcinoma via the tumor immune microenvironment analysis
por: Liu, Zhi-Yong, et al.
Publicado: (2022) -
A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Xu, Ru-Chen, et al.
Publicado: (2022) -
Sorafenib and CuB exert synergistic antitumor effects against hepatocellular carcinoma cells via inhibition of STAT3 phosphorylation
por: Wang, Xiaoli, et al.
Publicado: (2020) -
Plasmonic Cu(2−x)Se Mediated Colorimetric/Photothermal Dual-Readout Detection of Glutathione
por: Yan, Guojuan, et al.
Publicado: (2023) -
Stand-Alone CuFeSe(2) (Eskebornite) Nanosheets for Photothermal Cancer Therapy
por: Liu, Mimi, et al.
Publicado: (2021)